CMS' decision to open a second comment period for Kentucky's Medicaid waiver left legal experts puzzled.

The Office of Management and Budget is reviewing an internal final rule that could unfreeze risk adjustment payments to insurers.

The Trump administration is considering a proposal to overhaul safe harbor protections for pharmaceutical company rebates.

As part of the Trump administration's ongoing efforts on drug prices, the FDA will convene a work group to investigate importing certain medications.

A new analysis from the Altarum Institute found that spending and price growth among the privately insured sped up in 2017 and the first half of 2018 compared…

Amid increased scrutiny of the 340B program, the GAO has released a report diving into the characteristics of participating hospitals. 

The Maryland Health Care Commission expanded its price transparency initiative with hospital cost comparison tools for consumers.

The Massachusetts Health Policy Commission projects that the merger between Lahey Health and Beth Israel Deaconess could lead to higher prices. 

The new partnership gives UCSF a "digital front door" into Dignity's cloud-based platform designed to improve patient interactions.

The parent company of EHR vendor NextGen Healthcare has agreed to pay $19 million to resolve claims that company executives misled investors.